Reciprocity of approvals between FDA and its A-list foreign counterparts would ease the shortages.
Search results
An old wives tale makes a comeback: Cranberry juice
Ever wonder what it's like to participate in a medical study? When I signed up for a research study, I thought I’d learn something new about diet and health. It turns out that the real learning came from navigating blood tests, stool samples, and questionable food diaries — all while pretending that this was somehow a fun way to spend my time. At least I got a front-row seat to the unglamorous world of clinical research, where the hurdles are real, and the “patients” get a crash course in patience.
Despite a decade of people eyeing their phones like potential death traps, recent studies have put the final nail in the cell-phones-cause-cancer coffin. So, feel free to call, text, or scroll — your brain’s not going anywhere.
The U.S. has been adept at inventing The Next Big Thing, but sometimes stumbles when it comes to exploiting it. From cars to electronics, solar panels, and semiconductors, this pattern has been repeated. Biotechnology could be next unless we invest aggressively and regulate wisely.
It’s another of my (Henry Miller's) weekly appearances on Lars Larson’s radio show. In it, we discussed the resurgence of measles due to declining vaccination rates and touch on the potential role of vitamin D in mitigating COVID-19 severity.
Some patients taking weight-loss drugs, like Ozempic, are beginning to report slower or no weight loss as their bodies build up a tolerance to the medication. Does this spell trouble for obese people looking to slim down long-term? Dr. Chuck Dinerstein reports his personal experience with the so-called Ozempic plateau.
A standard is needed for all adversarial proceedings against doctors who treat pain, to establish which DEA or State Medical Board witnesses can be considered subject matter experts – and who cannot. The standard must follow the principle of the Supreme Court decision in Ruan vs. United States: Burden of proof must be on the government, not the doctor - who must be presumed innocent until the government proves that the doctor has intentionally engaged in practices that they knew were dangerous to the patient.
Obesity — it's the bad word everyone throws around, but few want to truly understand. The American Academy of Pediatricians thought it had it all figured out with its shiny new treatment guidelines. However, those “evidence-based” recommendations came crashing down faster than a late-night fast food binge. Instead of slapping on BMI labels like outdated fashion trends, we should think about what’s really feeding the obesity epidemic. And no, it’s not just the carbs.
The spectrum of information that can be obtained by prenatal testing is wide and rapidly increasing. Many mutations, or "abnormalities," are inconsequential, while others are significant. Genetic counseling combined with noninvasive prenatal screening (NIPS) can be helpful.
Vaccination remains one of the most effective tools in protecting public health, and maintaining high immunization rates is essential to preventing the resurgence of preventable diseases. However, rampant anti-vaccine disinformation largely driven by politicians, grifters, and “influencers” on television and social media undermines public confidence in vaccination.
In 2013, the American Heart Association (AHA) thought it had heart disease prevention all figured out with their trusty "risk calculator." Fast forward a decade to the new and improved PREVENT equations, promising to reflect a more diverse and current U.S. population. While the old calculator had us popping statins like candy, the new equations suggest many of us might not need them after all. Welcome to the latest chapter in the never-ending saga of heart health guidelines.
Historians may record that it was the confluence in time and space of two events the unprecedented success of the "Old Joe" Camel ads and the anticipated U.S. Supreme Court ruling against tobacco companies which triggered the beginning of the end for cigarette advertising in America.
That is the concensus of leading physicians, toxicologists and epidemiologists who met in New York on Wednesday to discuss the issue of food safety and pesticide use. In an unusual action, a panel of scientists, joined by 65 of their colleagues, signed a full-page advertisement that appeared Wednesday in major national newspapers, denouncing the recent pesticide scare.
This material has been published in Ecotoxicology and Environmental Safety 38, 71-84 (1997), the only definitive repository of the content that has been certified and accepted after peer review.
Proposals for drug legalization are rooted in the belief that drug prohibition does not work. Legalization advocates point out that the prohibition of alcohol failed in the United States two generations ago. They argue that the use of illicit drugs is widespread despite prohibition and that the high costs and negative consequences of that prohibition ranging from costs for police and prisons to the loss of privacy caused by drug testing in many settings, notably the workplace are unreasonably high prices to pay for an ineffective policy.
Scientists from the American Council on Science and Health today urged the nation's physicians and scientists to unite in rejecting any Congressionally sponsored "global deal" that would offer the cigarette industry immunity from current and future litigation. Such a deal which may be the product of negotiations now under way with the Philip Morris Cos. and RJR Nabisco Holdings Corp. was described in detail in a front-page article in the April 16, 1997, Wall Street Journal.
The overriding goal of federal policies governing the use of chemicals in agriculture and food processing is-and should be-consumer safety. One would hope that food safety regulation would be driven by the best scientific and medical knowledge. But instead, much of the American food supply is held hostage to the misguided absolutism of what is known as the Delaney clause, a nearly 40-year-old, 55-word quirk in the law. It reads, in its entirety:
The American Council on Science and Health today presented the "Poison Apple Award," given for the most shocking example of promoting, endorsing and glamorizing a deadly product to ELLE Magazine for encouraging cigarette use by its young female readers. ELLE earned this award for its May issue, which on page 219 contains a promotion for "the ELLE cigarette case," billing this "handsome and sophisticated antique-like silverplated case" as "the stylish way to transport your favorite brand."
Today's revelations that Philip Morris executives had suppressed internal company information on the addictive properties of nicotine, combined with the recent settlement of some lawsuits against tobacco companies, may mean that "at long last, tobacco companies are going to be held to the same standards of accountability as are all other businesses," declared Dr. Elizabeth M. Whelan, president of the American Council on Science and Health.
Recent research suggests that a fiber-rich diet may prevent and/or relieve various health conditions. Fiber is not a panacea, however. Dietary Fiber, a new Special Report from the American Council on Science and Health, summarizes current scientific knowledge about the health effects of this complex food component.
The American Council on Science and Health (ACSH) has announced the formation of an affiliate group, the New York City Advisory Council on Health Priorities ("Advisory Council"). This affiliate, funded by grants from two private New York City foundations (The Bodman and J. M. Foundations), will focus on public health issues of particular importance to New York City.
(From Priorities Vol. 8, No. 2, 1996)
FYI: What is a Medical Device? -- medical (download)
New York, NY, April 14, 1998 Scientists at the American Council on Science and Health today questioned a new report in The Journal of the American Medical Association (JAMA) that cites adverse reactions to drugs as the fourth-leading cause of death in the United States. The JAMA report, in the April 15th issue, is entitled Incidents of Adverse Drug Reaction in Hospitalized Patients.
The JAMA study fails to point out the almost incalculable number of lives saved each year as a result of properly prescribed pharmaceuticals,
New York, NY June 12, 1998. Olestra underwent one of the most extensive premarket testing programs of any food additive ever reviewed by the FDA. Since its approval in 1996, there has also been detailed post-marketing surveillance. This surveillance has demonstrated that the major objections to the use of olestra in salty snacks were without merit as detailed below with respect to two health-related aspects of olestra use.
Consumer Choice
Pagination
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!